The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Oestrogen receptor negative breast cancers exhibit high cytokine content
Open accessAbstract
Introduction: An emerging hypothesis suggests that cytokines could play an important role in cancer as potential modulators of angiogenesis and leucocyte infiltration. Methods: A novel multiplexed flow cytometry technology was used to measure the expression of 17 cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 [p70], IL-13, IL-17, granulocyte colony-stimulating factor [CSF], granulocyte-macrophage CSF, IFN-γ, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein [MIP]-1β, tumour necrosis factor [TNF]-α) at the protein level in 105 breast carcinoma. B lymphocyte, T lymphocyte and macrophage levels were determined by immunohistochemistry. Results: Fourteen of the 17 cytokines were expressed in breast carcinoma, whereas only nine cytokines could be detected in normal breast. Most cytokines were more abundant in breast carcinoma than in normal breast, with IL-6, IL-8, granulocyte CSF, IFN-γ, MCP-1 and MIP-1β being very abundant. IL-2, IL-6, IL-8, IL-10, IFN-γ, MCP-1, MIP-1β and TNF-α, and to a lesser extent IL-1β and IL-13 exhibited levels of expression that were inversely correlated to oestrogen receptor and progesterone receptor status. Most cytokines were not correlated with age at cancer diagnosis, tumour size, histological type, or lymph node status. However, IL-1β, IL-6, IL-8, IL-10, IL-12, MCP-1 and MIP-1β were more abundant in high-grade tumours than in low-grade tumours. In addition, IL-8 and MIP-1β were expressed to a greater degree in HER2-positive than in HER2-negative patients. The expression of most of the studied cytokines was correlated to levels of activator protein-1, which is known to regulate numerous cytokines. Overexpression of MCP-1 and MIP-1β were linked to B lymphocyte, T lymphocyte and macrophage infiltration, whereas high levels of IL-8 were correlated with high macrophage content in tumour. Moreover, IL-8 positive tumours exhibited increased vascularization. Conclusion: We found that multiple cytokines were overexpressed in oestrogen receptor negative breast carcinoma, and that the three major cytokines – MCP-1, MIP-1β and IL-8 – were correlated with inflammatory cell component, which could account for the aggressiveness of these tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Bloom, H. J. G., & Richardson, W. W. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.43 · Cited by 2,925
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease
Elenkov, I. J., & Chrousos, G. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00188-5 · Cited by 804
(2000) · PubMed · Cited by 706
CXC chemokines: the regulatory link between inflammation and angiogenesis
Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., & Romagnani, S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.006 · Cited by 409
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Saji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., & Toi, M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k · Cited by 288
Salem, M. (2004) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010043483944 · Cited by 288
Kozłowski, L., Zakrzewska, I., Tokajuk, P., & Wojtukiewicz, M. Z. (2003) · PubMed · Cited by 248
Freund, A., Chauveau, C., Brouillet, J.-P., Lucas, A., Lacroix, M., Licznar, A., Vignon, F., & Lazennec, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206113 · Cited by 224
Self-citationLin, Y., Huang, R., Chen, L., Li, S., Shi, Q., Jordan, C., & Huang, R. (2004) · International Journal of Cancer · doi:10.1002/ijc.11724 · Cited by 205
Serum Interleukin 6, Plasma VEGF, Serum VEGF, and VEGF Platelet Load in Breast Cancer Patients
Benoy, I., Salgado, R., Colpaert, C., Weytjens, R., Vermeulen, P. B., & Dirix, L. Y. (2002) · Clinical Breast Cancer · doi:10.3816/cbc.2002.n.008 · Cited by 188
The role of cytokines in the epithelial cancer microenvironment
Wilson, J., & Balkwill, F. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0419 · Cited by 174
Pantschenko, A., Pushkar, I., Anderson, K., Wang, Y., Miller, L., Kurtzman, S., Barrows, G., & Kreutzer, D. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.2.269 · Cited by 162
Wen, X.-F., Yang, G., Mao, W., Thornton, A., Liu, J., Bast, R. C., & Le, X.-F. (2006) · Oncogene · doi:10.1038/sj.onc.1209685 · Cited by 159
Fujimoto, J., Sakaguchi, H., Aoki, I., & Tamaya, T. (2000) · PubMed · Cited by 154
Green, A. R., Green, V. L., White, M. C., & Speirs, V. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970917)72:6<937::aid-ijc3>3.0.co;2-q · Cited by 137
Dissociative Glucocorticoid Activity of Medroxyprogesterone Acetate in Normal Human Lymphocytes
Bamberger, C. M., Else, T., Bamberger, A., Beil, F. U., & Schulte, H. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6091 · Cited by 116
17-β-ESTRADIOL SUPPRESSES IL-2 AND IL-2 RECEPTOR
McMurray, R. W., Ndebele, K., Hardy, K. J., & Jenkins, J. K. (2001) · Cytokine · doi:10.1006/cyto.2001.0900 · Cited by 108
Mechanisms underlying differential expression of interleukin-8 in breast cancer cells
Freund, A., Jolivel, V., Durand, S., Kersual, N., Chalbos, D., Carine Chavey, A., Vignon, F., & Lazennec, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207815 · Cited by 104
Self-citationInterleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines.
Chiu, J., Sgagias, M. K., & Cowan, K. H. (1996) · PubMed · Cited by 99
Bamberger, A., Methner, C., Lisboa, B., Städtler, C., Schulte, H. M., Löning, T., & Milde‐Langosch, K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<533::aid-ijc16>3.0.co;2-j · Cited by 99
Loudon, J. A. Z., Elliott, C. L., Hills, F. A., & Bennett, P. R. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.013698 · Cited by 85
Interleukin-1 Family Expression in Human Breast Cancer: Interleukin-1 Receptor Antagonist
MILLER, L. J., Kurtzman, S. H., Anderson, K. L., Wang, Y., Stankus, M., Renna, M., Lindquist, R. R., Barrows, G. H., & Kreutzer, D. L. (2000) · Cancer Investigation · doi:10.3109/07357900009012171 · Cited by 85
High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours
Venetsanakos, E., Beckman, I., Bradley, J., & Skinner, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.311 · Cited by 80
Carruba, G., D’Agostino, P., Miele, M., Calabrò, M., Barbera, C., Bella, G. D., Milano, S., Ferlazzo, V., Caruso, R., Rosa, M. L., et al. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10607 · Cited by 69
Singer, C. F., Kronsteiner, N., Hudelist, G., Márton, E., Walter, I., Kubista, M., Czerwenka, K. F., Schreiber, M., Seifert, M., & Kubista, E. (2003) · PubMed · Cited by 66
17beta-Estradiol Inhibits MCP-1 Production in Human Keratinocytes
Kanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1038/jid.2003.12 · Cited by 53
Curran, E. M., Judy, B. M., NEWTON, L. G., Lubahn, D. B., Rottinghaus, G. E., MacDonald, R. S., Franklin, C. L., & Estes, D. M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02368.x · Cited by 52
The significant role of telomerase activity in human brain tumors
Nakatani, K., Yoshimi, N., Mori, H., Yoshimura, S.-I., Sakai, H., Shinoda, J., & Sakai, N. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3<421::aid-cncr10>3.0.co;2-z · Cited by 50
The Inhibition of Synthesis of a β-Chemokine, Monocyte Chemotactic Protein-1 (MCP-1) by Progesterone
KELLY, R. W., Carr, G. G., & Riley, S. C. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7502 · Cited by 50
Boon, T., & den Eynde, B. V. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00010-4 · Cited by 36
Skoog, L. K., Humla, S., Axelsson, M., Frost, M., Norman, A., Nordenskjöld, B. A., & Wallgren, A. (1987) · Acta Oncologica · doi:10.3109/02841868709091747 · Cited by 35
Davies, S., Dai, D., Wolf, D. M., et al. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2004.04.003 · Cited by 30
Nakaya, M., Yamasaki, M., Miyazaki, Y., Tachibana, H., & Yamada, K. (2003) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1543-706x(2003)039<0383:ecsipi>2.0.co;2 · Cited by 23
17beta-Estradiol Inhibits MCP-1 Production in Human Keratinocytes
Kanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12255.x · Cited by 23
Fanti, P., Nazareth, M. R., Bucelli, R. C., Mineo, M., Gibbs, K., Kumin, M., Grzybek, K., Raiber, L., Poppenberg, K., Janis, K. L., et al. (2003) · Endocrine · doi:10.1385/endo:22:2:161 · Cited by 18
Cited by
Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells
Sullivan, N. J., Sasser, A. K., Axel, A. E., Vesuna, F., Raman, V, Ramirez, N., Oberyszyn, T. M., & Hall, B. M. (2009) · Oncogene · doi:10.1038/onc.2009.180 · Cited by 757
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Bonapace, L., Coissieux, M.-M., Wyckoff, J., Mertz, K. D., Varga, Z., Junt, T., & Bentires-Alj, M. (2014) · Nature · doi:10.1038/nature13862 · Cited by 665
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 650
Self-citationThe inflammatory chemokines CCL2 and CCL5 in breast cancer
Soria, G., & Ben-Baruch, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.018 · Cited by 593
Metadata
- Authors
- Chavey, C., Bibeau, F., Gourgou-Bourgade, S., Burlinchon, S., Boissière, F., Laune, D., Roques, S., & Lazennec, G.
- Venue
- Breast Cancer Research
- Published
- 2007-01-29
- Volume
- 9
- Issue
- 1
- Pages
- R15-R15
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W1518308640
- Cited by
- 349
- References
- 39
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.